Carl Zeiss Meditec AG (OTCMKTS:CZMWY – Get Free Report) was the target of a significant drop in short interest in January. As of January 15th, there was short interest totaling 1,276 shares, a drop of 14.2% from the December 31st total of 1,487 shares. Based on an average daily volume of 5,917 shares, the short-interest ratio is presently 0.2 days. Based on an average daily volume of 5,917 shares, the short-interest ratio is presently 0.2 days.
Analysts Set New Price Targets
CZMWY has been the subject of a number of research analyst reports. The Goldman Sachs Group lowered shares of Carl Zeiss Meditec from a “buy” rating to a “neutral” rating in a report on Tuesday, January 20th. Sanford C. Bernstein downgraded shares of Carl Zeiss Meditec to a “market perform” rating in a report on Monday, January 26th. One investment analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Carl Zeiss Meditec presently has an average rating of “Hold”.
Read Our Latest Research Report on CZMWY
Carl Zeiss Meditec Stock Performance
About Carl Zeiss Meditec
Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.
The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.
Read More
- Five stocks we like better than Carl Zeiss Meditec
- The day the gold market broke
- Buy this Gold Stock Before May 2026
- Forget AI, This Will Be the Next Big Tech Breakthrough
- Trump Planning to Use Public Law 63-43: Prepare Now
- New gold price target
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
